Nilotinib monohydrochloride monohydrate

SKU: orb1306342

Description

Nilotinib monohydrochloride monohydrate is a potent second-generation BCR-ABL tyrosine kinase inhibitor effective against numerous mutant forms. It is widely used in biochemical and cellular research to study kinase inhibition, resistance mechanisms, and in preclinical models of chronic myeloid leukemia.

Research Area

Cardiovascular Research, Cell Biology, Signal Transduction

Key Properties

• CAS Number: 923288-90-8
• MW: 583.99
• Purity: 99.93% (May vary between batches)
• Formula: C₂₈H₂₂F₃N₇O.HCl.H₂O
• SMILES: O.Cl.Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F
• Target: Bcr-Abl,Autophagy
• Solubility: DMSO:45 mg/mL (77.06 mM);10% DMSO+90% Corn Oil:4 mg/mL (6.85 mM)

Bioactivity

• In Vivo:
  In the indomethacin-induced enterocolitis rat model, nilotinib has a positive effect on the macroscopic and microscopic pathologic scores, ensuring considerable mucosal healing. Nilotinib decreases PDGFR α and β levels and increases the colonic apoptotic scores.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

tyrosine kinase, inhibit, Nilotinib, Nilotinib (monohydrochloride monohydrate), Nilotinib monohydrochloride, Nilotinib monohydrochloride Monohydrate, Nilotinib monohydrochloride monohydrate, Inhibitor, Autophagy, antitumor, AMN-107, AMN107 (monohydrochloride monohydrate), AMN107 monohydrochloride, AMN107, AMN 107, BcrAbl, Bcr-Abl

Compound Identifiers

PubChem CID

16757572